Methyl-β-cyclodextrin enhances the susceptibility of human breast cancer cells to carboplatin and 5-fluorouracil: Involvement of Akt, NF-κB and Bcl-2
- 19 May 2006
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 216 (2) , 177-185
- https://doi.org/10.1016/j.taap.2006.05.009
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- DNA damaging drugs-induced down-regulation of Bcl-2 is essential for induction of apoptosis in high-risk HPV-positive HEp-2 and KB cellsCancer Letters, 2006
- Mechanistic and Predictive Profiling of 5-Fluorouracil Resistance in Human Cancer CellsCancer Research, 2004
- Overexpression of caveolin-1 increases plasma membrane fluidity and reduces P-glycoprotein function in Hs578T/DoxBiochemical and Biophysical Research Communications, 2004
- Carboplatin induces apoptotic cell death through downregulation of constitutively active nuclear factor-κB in human HPV-18 E6-positive HEp-2 cellsBiochemical and Biophysical Research Communications, 2004
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- NF-κB at the crossroads of life and deathNature Immunology, 2002
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- In vitro modulation of doxorubicin and docetaxel antitumoral activity by methyl-β-cyclodextrinEuropean Journal Of Cancer, 1998
- Novel Oral Drug FormulationsDrug Safety, 1994
- Drug solubilizers to aid pharmacologists: Amorphous cyclodextrin derivativesLife Sciences, 1988